122 related articles for article (PubMed ID: 34092413)
1. Risk of secondary malignancies in ovarian cancer survivors: 52,680 patients analyzed with over 40 years of follow-up.
Casper AC; Parsons MW; Chipman J; Burt LM; Suneja G; Maurer KA; Gaffney DK
Gynecol Oncol; 2021 Aug; 162(2):454-460. PubMed ID: 34092413
[TBL] [Abstract][Full Text] [Related]
2. Secondary malignancies in non-Hodgkin lymphoma survivors: 40 years of follow-up assessed by treatment modality.
Parsons MW; Rock C; Chipman JJ; Shah HR; Hu B; Stephens DM; Tao R; Tward JD; Gaffney DK
Cancer Med; 2023 Feb; 12(3):2624-2636. PubMed ID: 36812123
[TBL] [Abstract][Full Text] [Related]
3. Second nonbreast malignancies after conservative surgery and radiation therapy for early-stage breast cancer.
Galper S; Gelman R; Recht A; Silver B; Kohli A; Wong JS; Van Buren T; Baldini EH; Harris JR
Int J Radiat Oncol Biol Phys; 2002 Feb; 52(2):406-14. PubMed ID: 11872286
[TBL] [Abstract][Full Text] [Related]
4. Do survivors of borderline ovarian tumors have susceptibility to secondary primary malignancies? A SEER population-based study.
Wang J; Du Y; Kang Y
Int J Gynaecol Obstet; 2024 Jun; 165(3):1229-1236. PubMed ID: 38205842
[TBL] [Abstract][Full Text] [Related]
5. The risk of secondary malignancies over 30 years after the treatment of non-Hodgkin lymphoma.
Tward JD; Wendland MM; Shrieve DC; Szabo A; Gaffney DK
Cancer; 2006 Jul; 107(1):108-15. PubMed ID: 16708354
[TBL] [Abstract][Full Text] [Related]
6. Risk of Second Primary Tumors After Childhood and Adolescent Ovarian Malignancies: A SEER Analysis (1973-2011).
Nasioudis D; Ramer I; Sisti G; Fambrini M
J Pediatr Adolesc Gynecol; 2015 Dec; 28(6):522-5. PubMed ID: 26152647
[TBL] [Abstract][Full Text] [Related]
7. Second malignancy in young early-stage breast cancer patients with modern radiotherapy: A long-term population-based study (A STROBE-compliant study).
Xie L; Lin C; Zhang H; Bao X
Medicine (Baltimore); 2018 Apr; 97(17):e0593. PubMed ID: 29703057
[TBL] [Abstract][Full Text] [Related]
8. Risk of second malignancies among survivors of pediatric thyroid cancer.
Adly MH; Sobhy M; Rezk MA; Ishak M; Afifi MA; Shafie AE; Ali MA; Zekri W; Alfaar AS; Rashed WM
Int J Clin Oncol; 2018 Aug; 23(4):625-633. PubMed ID: 29492793
[TBL] [Abstract][Full Text] [Related]
9. Risk of secondary malignancies after radiation therapy for breast cancer: Comprehensive results.
Burt LM; Ying J; Poppe MM; Suneja G; Gaffney DK
Breast; 2017 Oct; 35():122-129. PubMed ID: 28719811
[TBL] [Abstract][Full Text] [Related]
10. Risk of metachronous ovarian cancer after ovarian conservation in young women with stage I cervical cancer.
Matsuo K; Machida H; Horowitz MP; Shahzad MMK; Guntupalli SR; Roman LD; Wright JD
Am J Obstet Gynecol; 2017 Nov; 217(5):580.e1-580.e10. PubMed ID: 28666700
[TBL] [Abstract][Full Text] [Related]
11. Declining second primary ovarian cancer after first primary breast cancer.
Schonfeld SJ; Berrington de Gonzalez A; Visvanathan K; Pfeiffer RM; Anderson WF
J Clin Oncol; 2013 Feb; 31(6):738-43. PubMed ID: 23284037
[TBL] [Abstract][Full Text] [Related]
12. Risk of second primary cancers among survivors of gynecological cancers.
Adjei Boakye E; Grubb L; Peterson CE; Osazuwa-Peters N; Grabosch S; Ladage HD; Huh WK
Gynecol Oncol; 2020 Sep; 158(3):719-726. PubMed ID: 32616403
[TBL] [Abstract][Full Text] [Related]
13. Second primary malignancies after ovarian cancer: A SEER-based analysis (1975-2016).
Yang Z; Liu X; Yang X; Liao QP
Taiwan J Obstet Gynecol; 2022 Jan; 61(1):80-85. PubMed ID: 35181052
[TBL] [Abstract][Full Text] [Related]
14. Risk of Second Primary Female Genital Malignancies in Women with Breast Cancer: a SEER Analysis.
Li Z; Wu Q; Song J; Zhang Y; Zhu S; Sun S
Horm Cancer; 2018 Jun; 9(3):197-204. PubMed ID: 29556910
[TBL] [Abstract][Full Text] [Related]
15. Second Primary Malignancies in Mantle Cell Lymphoma: A US Population-based Study.
Shah BK; Khanal A
Anticancer Res; 2015 Jun; 35(6):3437-40. PubMed ID: 26026107
[TBL] [Abstract][Full Text] [Related]
16. Second malignancies after adjuvant radiation therapy for early stage breast cancer: is there increased risk with addition of regional radiation to local radiation?
Hamilton SN; Tyldesley S; Li D; Olson R; McBride M
Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):977-85. PubMed ID: 25832690
[TBL] [Abstract][Full Text] [Related]
17. The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer.
Brown AP; Chen J; Hitchcock YJ; Szabo A; Shrieve DC; Tward JD
J Clin Endocrinol Metab; 2008 Feb; 93(2):504-15. PubMed ID: 18029468
[TBL] [Abstract][Full Text] [Related]
18. Second primary ovarian cancer among women diagnosed previously with cancer.
Hall HI; Jamison P; Weir HK
Cancer Epidemiol Biomarkers Prev; 2001 Sep; 10(9):995-9. PubMed ID: 11535553
[TBL] [Abstract][Full Text] [Related]
19. Trends in the risk and burden of second primary malignancy among survivors of smoking-related cancers in the United States.
Adjei Boakye E; Buchanan P; Hinyard L; Osazuwa-Peters N; Simpson MC; Schootman M; Piccirillo JF
Int J Cancer; 2019 Jul; 145(1):143-153. PubMed ID: 30613963
[TBL] [Abstract][Full Text] [Related]
20. Second malignancies in long-term testicular cancer survivors.
Ondrus D; Ondrusova M; Friedova L
Int Urol Nephrol; 2014 Apr; 46(4):749-56. PubMed ID: 24096370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
